These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38140828)

  • 41. Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer.
    Wang L; Tong X; Zhou Z; Wang S; Lei Z; Zhang T; Liu Z; Zeng Y; Li C; Zhao J; Su Z; Zhang C; Liu X; Xu G; Zhang HT
    Mol Cancer; 2018 Sep; 17(1):140. PubMed ID: 30261900
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Altered β1,6-GlcNAc branched N-glycans impair TGF-β-mediated epithelial-to-mesenchymal transition through Smad signalling pathway in human lung cancer.
    Li N; Xu H; Fan K; Liu X; Qi J; Zhao C; Yin P; Wang L; Li Z; Zha X
    J Cell Mol Med; 2014 Oct; 18(10):1975-91. PubMed ID: 24913443
    [TBL] [Abstract][Full Text] [Related]  

  • 43. BIX02189 inhibits TGF-β1-induced lung cancer cell metastasis by directly targeting TGF-β type I receptor.
    Park SJ; Choi YS; Lee S; Lee YJ; Hong S; Han S; Kim BC
    Cancer Lett; 2016 Oct; 381(2):314-22. PubMed ID: 27543359
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Investigating the effects of Pirfenidone on TGF-β1 stimulated non-SMAD signaling pathways in Dupuytren's disease -derived fibroblasts.
    Zhou C; Zeldin Y; Baratz ME; Kathju S; Satish L
    BMC Musculoskelet Disord; 2019 Mar; 20(1):135. PubMed ID: 30927912
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pirfenidone suppressed triple-negative breast cancer metastasis by inhibiting the activity of the TGF-β/SMAD pathway.
    Luo D; Zeng X; Zhang S; Li D; Cheng Z; Wang Y; Long J; Hu Z; Long S; Zhou J; Zhang S; Zeng Z
    J Cell Mol Med; 2023 Feb; 27(3):456-469. PubMed ID: 36651490
    [TBL] [Abstract][Full Text] [Related]  

  • 46. TGF-β1-induced epithelial-mesenchymal transition in lung cancer cells involves upregulation of miR-9 and downregulation of its target, E-cadherin.
    Wang H; Wu Q; Zhang Y; Zhang HN; Wang YB; Wang W
    Cell Mol Biol Lett; 2017; 22():22. PubMed ID: 29118814
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interaction between non-small-cell lung cancer cells and fibroblasts via enhancement of TGF-β signaling by IL-6.
    Abulaiti A; Shintani Y; Funaki S; Nakagiri T; Inoue M; Sawabata N; Minami M; Okumura M
    Lung Cancer; 2013 Nov; 82(2):204-13. PubMed ID: 24011634
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In-vitro Pre-Treatment of Cancer Cells with TGF-β1: A Novel Approach of Tail Vein Lung Cancer Metastasis Mouse Model for Anti-Metastatic Studies.
    Khan GJ; Sun L; Abbas M; Naveed M; Jamshaid T; Baig MMFA; Yuan S
    Curr Mol Pharmacol; 2019; 12(4):249-260. PubMed ID: 30848226
    [TBL] [Abstract][Full Text] [Related]  

  • 49. sFRP1 inhibits epithelial-mesenchymal transition in A549 human lung adenocarcinoma cell line.
    Ren J; Wang R; Huang G; Song H; Chen Y; Chen L
    Cancer Biother Radiopharm; 2013 Sep; 28(7):565-71. PubMed ID: 23802127
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Celecoxib and sulindac inhibit TGF-β1-induced epithelial-mesenchymal transition and suppress lung cancer migration and invasion via downregulation of sirtuin 1.
    Cha BK; Kim YS; Hwang KE; Cho KH; Oh SH; Kim BR; Jun HY; Yoon KH; Jeong ET; Kim HR
    Oncotarget; 2016 Aug; 7(35):57213-57227. PubMed ID: 27528025
    [TBL] [Abstract][Full Text] [Related]  

  • 51. FPPS mediates TGF-β1-induced non-small cell lung cancer cell invasion and the EMT process via the RhoA/Rock1 pathway.
    Lin L; Li M; Lin L; Xu X; Jiang G; Wu L
    Biochem Biophys Res Commun; 2018 Feb; 496(2):536-541. PubMed ID: 29337059
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Downregulation of miR-3127-5p promotes epithelial-mesenchymal transition via FZD4 regulation of Wnt/β-catenin signaling in non-small-cell lung cancer.
    Yang Y; Sun Y; Wu Y; Tang D; Ding X; Xu W; Su B; Gao W
    Mol Carcinog; 2018 Jul; 57(7):842-853. PubMed ID: 29566281
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MARVELD1 modulates cell surface morphology and suppresses epithelial-mesenchymal transition in non-small cell lung cancer.
    Yao Y; Shi M; Liu S; Li Y; Guo K; Ci Y; Liu W; Li Y
    Mol Carcinog; 2016 Nov; 55(11):1714-1727. PubMed ID: 26509557
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ginsenoside Rb2 inhibits epithelial-mesenchymal transition of colorectal cancer cells by suppressing TGF-β/Smad signaling.
    Dai G; Sun B; Gong T; Pan Z; Meng Q; Ju W
    Phytomedicine; 2019 Mar; 56():126-135. PubMed ID: 30668333
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer.
    Takai K; Le A; Weaver VM; Werb Z
    Oncotarget; 2016 Dec; 7(50):82889-82901. PubMed ID: 27756881
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pedunculoside inhibits epithelial-mesenchymal transition and overcomes Gefitinib-resistant non-small cell lung cancer through regulating MAPK and Nrf2 pathways.
    Fan Q; Liang X; Xu Z; Li S; Han S; Xiao Y; Xu Q; Yuan R; Yang S; Gao H
    Phytomedicine; 2023 Jul; 116():154884. PubMed ID: 37209605
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tannic acid attenuates TGF-β1-induced epithelial-to-mesenchymal transition by effectively intervening TGF-β signaling in lung epithelial cells.
    Pattarayan D; Sivanantham A; Krishnaswami V; Loganathan L; Palanichamy R; Natesan S; Muthusamy K; Rajasekaran S
    J Cell Physiol; 2018 Mar; 233(3):2513-2525. PubMed ID: 28771711
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of FOXJ2 on TGF-β1-induced epithelial-mesenchymal transition through Notch signaling pathway in non-small lung cancer.
    Yang Q; Cao X; Tao G; Zhou F; Zhao P; Shen Y; Chen X
    Cell Biol Int; 2017 Jan; 41(1):79-83. PubMed ID: 27611107
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tri-methylation of H3K79 is decreased in TGF-β1-induced epithelial-to-mesenchymal transition in lung cancer.
    Evanno E; Godet J; Piccirilli N; Guilhot J; Milin S; Gombert JM; Fouchaq B; Roche J
    Clin Epigenetics; 2017; 9():80. PubMed ID: 28804523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.